ArticleFrontiers in radiology2025
U-FDL-PPE: a unified federated deep learning framework with privacy-preserving explainability for early and accurate viral disease prediction.
Article in Frontiers in radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Federated deep learning for stroke detection: a privacy-preserving, explainable CNN-LSTM framework.Frontiers in neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Early and accurate detection of viral diseases is vital for timely treatment and public health preparedness. However, most existing computer-based prediction systems depend on centralized data storage, which raises concerns about patient privacy, compatibility between different hospitals, and limited clarity on how predictions are made. To address these issues, this study introduces U-FDL-PPE, a new federated deep-learning framework designed to support early and reliable viral disease diagnosis while protecting patient confidentiality and offering clear and understandable prediction insights. Methods: The framework uses a decentralized learning approach that allows hospitals to train models collaboratively without exchanging raw medical images. MobileNetV2 was used as the core model for classifying chest X-rays, and Grad-CAM was included to produce heatmaps that visually explain how the model arrived at its decisions. The system was tested using the publicly available COVID-19 Radiography Database in a simulated network of three healthcare institutions. Model performance was evaluated using standard measures such as accuracy, F1-score, AUC, and confusion matrix. Results: Across five training rounds, U-FDL-PPE recorded 88% accuracy, an F1-score of 89.66%, and a multi-class AUC of 0.5192. The confusion matrix showed consistently correct predictions across the three diagnostic categories: COVID-19, Normal, and Viral Pneumonia. The Grad-CAM heatmaps highlighted medically relevant lung regions, confirming that the framework focused on features that clinicians would expect when diagnosing these conditions. Discussion: The results indicate that U-FDL-PPE is a practical and scalable solution for early viral disease diagnosis, particularly in environments where patient privacy must be preserved. Its combination of decentralized training and visual explanation builds greater trust among clinicians while ensuring that sensitive medical data never leaves the originating institution. The lightweight MobileNetV2 architecture also supports faster processing, making the system suitable for hospitals and clinics with limited computing resources. Overall, U-FDL-PPE provides a privacy-conscious and transparent diagnostic framework that is well-positioned for real-world implementation across healthcare networks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.